Health - Mundipharma
The company is dedicated to providing patients with severe and debilitating diseases the benefit of new treatment options in fields such as pain, oncology, oncology supportive care, ophthalmology, respiratory disease and consumer healthcare.
Most recently, Mundipharma has developed a new Asthma Mobile Application which is designed to enhance communication between doctors and patients – and enable asthma sufferers to keep track of and improve their asthma care. It will improve patient inhaler technique and in turn enable better outcomes for asthma sufferers in the Middle East region. The App will be free to download on both iPhone and Android platforms.
There is a great need for this application as, according to the Global Asthma Report 2014, more than 334 million people worldwide suffer from asthma and almost half of them are not optimally controlled.1
According to a study conducted in the UAE, 12-15% of adults across the country suffer from this chronic condition.
“One of the biggest issues is that the control of asthma remains sub-optimal. Despite advances, patients’ inhaler-use technique has not improved in 40 years. We seek to change that,” said Dr Mohamed Samir of Mundipharma.2&3
“This is important as there are multiple inhalers requiring varying inhaling techniques and knowing how to properly use a specific inhaler will ensure the asthma inhaler is being used correctly so the asthma sufferer will get the full benefit of the medication,” Dr Samir added.
Commenting on the company’s innovation, Dr Ashraf Allam, Vice President of Mundipharma Middle East & Africa, said: “Mundipharma’s history and focus in innovation has made us one of the fastest growing pharmaceutical companies globally and keeps us committed to meeting the demand for patient-centric solutions. We have started to harness the power of digital innovation to bridge the gap to optimal patient care. Utilizing Occulus Rift [a virtual reality headset], we are the first company in the Middle East to use virtual reality to enhance the learning experience for physicians and patients.”
At a recent conference sponsored by Mundipharma in Dubai, doctors in the Middle East & Africa were invited to be the first in the world to view and test the application.
Dr Bassam Mahboub, Consultant & Head of Pulmonary Medicine at Rashid Hospital & Chief Innovation Officer at The Dubai Health Authority, commented: “Respiratory health in the region continues to improve, but we need to see more innovation.”
The App will help patients improve their asthma management in general, by capturing their symptoms, seeking advice from an expert, learning about their disease & getting tips on how to better manage their disease, as well as how to properly use their inhaler. The App will also provide reminders and monitor frequency of medicationuse and prescription renewals, as well as provide emergency contacts.
These kinds of applications are clever, digital innovations which are very simple in use. They are developed to help improve the positive outcome of the treatment and consequently make patients healthier and happier.
1. The Global Asthma Report 2014. www.globalasthmareport.org
2. Mahboub BH, Al-Hammadi S, Rafique M, et al. Population prevalence of asthma and its determinants based on European Community Respiratory Health Survey in the United Arab Emirates. BMC Pulm Med 2012; 2:4.)
3. Sanchis J, et al. CHEST, Volume 150, Issue 2, August 2016, Pages 394–406
|Date of upload: 20th Jan 2017|
Copyright © 2017 MiddleEastHealthMag.com. All Rights Reserved.